We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Waxman: Planned Guidance Could Open Loophole for Off-Label Promotion
Waxman: Planned Guidance Could Open Loophole for Off-Label Promotion
December 7, 2007
Rep. Henry Waxman (D-Calif.) is urging the FDA not to release a guidance allowing drug and medical device companies to use journal articles to promote off-label use of their products.